Categories: SCHD24

Leaders in Health Equity Honored by the Binaytara Foundation

Announcing the 2024 Award Recipients for Humanitarianism, Distinguished Faculty, and Volunteer of the Year

 

Statement from Dr. Binay Shah

 

The Binaytara Foundation (BTF) is a global cancer non-profit dedicated to improving access to cancer care in the United States and abroad through education and innovative program models that break down barriers and advance best practices in hematology and oncology. The Binaytara Foundation’s major projects include hematology and oncology conferences and the establishment of a cancer hospital in Nepal. Donate here!

 

The Binaytara Foundation’s annual awards for Humanitarianism, Distinguished Faculty, and Volunteer of the Year will be presented at this year’s gala, to be held on April 27, 2024, from 6:00-8:30 PM, at the Grand Hyatt in Seattle, Washington. The event will include entertainment, live and silent auctions, dining, learning, friendship, and more – all in support of BTF’s mission. Purchase tickets here!

 

2024 Distinguished Faculty 

The Binaytara Foundation’s Distinguished Faculty Award recognizes individuals who have demonstrated long-standing excellence in teaching and improving access to education for healthcare providers.

This year’s Distinguished Faculty Awards go to Dr. George Rodgers and Dr. Ulka Vaishampayan.

Dr. Vaishampayan and Dr. Rodgers have been valued members of the Binaytara Foundation Faculty Community, extensively contributing as distinguished speakers at national conferences. Their insights and presentations consistently receive high acclaim from both colleagues and participants. Thank you, Dr. Vaishampayam and Dr. Rodgers, for your vital role in advancing the Binaytara Foundation’s mission!

 

 

2024 Humanitarian Award

The Binaytara Foundation Humanitarian Award recognizes individuals who demonstrate the foundation’s core values through their volunteer work, community engagement, and dedication to improving access to cancer care.

This year’s award will be presented to Dr. Ana María López, a trailblazer in health equity research, relentlessly advancing diversity, equity, and inclusion in medicine. Her leadership at the Binaytara Foundation’s Summits on Cancer Health Disparities has been pivotal in driving critical conversations and actions to address cancer health disparities. Congratulations, Dr. López, on your impactful work!

 

 

 

2024 Volunteer of the Year 

Dr. Anish Shah will be named the Binaytara Foundation’s Volunteer of the Year for 2024. Dr. Anish Shah, originally from Janakpur, Nepal, has played 

an instrumental role in implementing electronic medical records at the Binaytara Foundation Cancer Hospital in Nepal. We deeply appreciate Dr. Shah’s dedication and impactful contributions. Thank you, Dr. Shah!

 

Elaina Harris

Recent Posts

ADRIATIC: durvalumab (D) as consolidation treatment (tx) for patients (pts) with limited-stage small-cell lung cancer (LS-SCLC)

By: Tiantian Zhang1, Yiqun Han2, Lei Deng3 1. Department of Internal Medicine, University of Central…

5 months ago

ASCO24 LAURA Trial Summary

By: Zhiting Tang1, Lei Deng21. Unity Hospital, Rochester Regional Health, Rochester, NY2. University of Washington/Fred…

5 months ago

FDA Approves Tovorafenib for Pediatric Low-Grade Glioma With BRAF Mutation

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 23, 2024, the U.S. Food and Drug…

6 months ago

FDA Approves Tisotumab Vedotin for Recurrent or Metastatic Cervical Cancer

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 29, 2024, the U.S. Food and Drug…

6 months ago

FDA Approves Lutetium Lu 177 Dotatate for SSTR-Positive Gastroenteropancreatic Neuroendocrine Tumors

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 23, 2024, the U.S. Food and Drug…

6 months ago

FDA Approves Alectinib for Adjuvant Treatment in Non-Small Cell Lung Cancer

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 18, 2024, the U.S. Food and Drug…

6 months ago